Chimeric Antigen Receptor T-Cell Therapy in Lung Cancer: Potential and Challenges

Chimeric antigen receptor T (CAR-T) cell therapy has exhibited a substantial clinical response in hematological malignancies, including B-cell leukemia, lymphoma, and multiple myeloma. Therefore, the feasibility of using CAR-T cells to treat solid tumors is actively evaluated. Currently, multiple ba...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiao, Bu-Fan, Zhang, Jing-Tao, Zhu, Yu-Ge, Cui, Xin-Run, Lu, Zhe-Ming, Yu, Ben-Tong, Wu, Nan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8591168/
https://www.ncbi.nlm.nih.gov/pubmed/34790207
http://dx.doi.org/10.3389/fimmu.2021.782775

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8591168/
https://www.ncbi.nlm.nih.gov/pubmed/34790207
http://dx.doi.org/10.3389/fimmu.2021.782775

Ejemplares similares